SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cancer - Side effect drugs
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who started this subject5/18/2002 7:40:57 PM
From: John McCarthy   of 57
 
[2002]-[ONT-093]-[oral P-gp inhibitor][FUTURE ONCOLOGY]

All in all, this issue of FUTURE ONCOLOGY covers:

agents used in combination with taxanes to fight MDR and/or mitigate the drugs' side effects including AVI-4557, BNP7787, cyclosporin A and analogs/derivatives, GF120918, ONT-093, Prosaptide, R101933, tRA96023, VX-710, and XR9576

oncologyknowledgebase.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News